ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CKD and ESRD Treatment Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-22D10270
Home | Market Reports | Health| Health Conditions
Global CKD and ESRD Treatment Market Research Report 2022
BUY CHAPTERS

Global CKD and ESRD Treatment Market Research Report 2025

Code: QYRE-Auto-22D10270
Report
February 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
NIKKISO
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic Inc
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Astrazeneca plc
Vifor Pharma

CKD and ESRD Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

CKD and ESRD Treatment Market

CKD and ESRD Treatment Market

The global market for CKD and ESRD Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
If left untreated, CKD can progress to kidney failure and early cardiovascular disease. When the kidneys stop working, dialysis or kidney transplant is needed for survival. Kidney failure treated with dialysis or kidney transplant is called end-stage renal disease (ESRD).
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CKD and ESRD Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CKD and ESRD Treatment.
The CKD and ESRD Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CKD and ESRD Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CKD and ESRD Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CKD and ESRD Treatment Market Report

Report Metric Details
Report Name CKD and ESRD Treatment Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical, AstraZeneca, Vifor Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CKD and ESRD Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CKD and ESRD Treatment Market report?

Ans: The main players in the CKD and ESRD Treatment Market are Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, Guangdong Biolight, Medtronic, Sanxin Medtec, Jafron Biomedical, SWS Hemodialysis Care, Tianyi Medical, AstraZeneca, Vifor Pharma

What are the Application segmentation covered in the CKD and ESRD Treatment Market report?

Ans: The Applications covered in the CKD and ESRD Treatment Market report are Hospitals, Kidney Dialysis Centers, At Homes, Others

What are the Type segmentation covered in the CKD and ESRD Treatment Market report?

Ans: The Types covered in the CKD and ESRD Treatment Market report are Medicine, Hemodialysis, Peritoneal Dialysis, Kidney Transplantation

Recommended Reports

Renal Disease Markets

Urology Therapeutics

Chronic Disease Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CKD and ESRD Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medicine
1.2.3 Hemodialysis
1.2.4 Peritoneal Dialysis
1.2.5 Kidney Transplantation
1.3 Market by Application
1.3.1 Global CKD and ESRD Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CKD and ESRD Treatment Market Perspective (2020-2031)
2.2 Global CKD and ESRD Treatment Growth Trends by Region
2.2.1 Global CKD and ESRD Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CKD and ESRD Treatment Historic Market Size by Region (2020-2025)
2.2.3 CKD and ESRD Treatment Forecasted Market Size by Region (2026-2031)
2.3 CKD and ESRD Treatment Market Dynamics
2.3.1 CKD and ESRD Treatment Industry Trends
2.3.2 CKD and ESRD Treatment Market Drivers
2.3.3 CKD and ESRD Treatment Market Challenges
2.3.4 CKD and ESRD Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CKD and ESRD Treatment Players by Revenue
3.1.1 Global Top CKD and ESRD Treatment Players by Revenue (2020-2025)
3.1.2 Global CKD and ESRD Treatment Revenue Market Share by Players (2020-2025)
3.2 Global CKD and ESRD Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CKD and ESRD Treatment Revenue
3.4 Global CKD and ESRD Treatment Market Concentration Ratio
3.4.1 Global CKD and ESRD Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CKD and ESRD Treatment Revenue in 2024
3.5 Global Key Players of CKD and ESRD Treatment Head office and Area Served
3.6 Global Key Players of CKD and ESRD Treatment, Product and Application
3.7 Global Key Players of CKD and ESRD Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CKD and ESRD Treatment Breakdown Data by Type
4.1 Global CKD and ESRD Treatment Historic Market Size by Type (2020-2025)
4.2 Global CKD and ESRD Treatment Forecasted Market Size by Type (2026-2031)
5 CKD and ESRD Treatment Breakdown Data by Application
5.1 Global CKD and ESRD Treatment Historic Market Size by Application (2020-2025)
5.2 Global CKD and ESRD Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CKD and ESRD Treatment Market Size (2020-2031)
6.2 North America CKD and ESRD Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CKD and ESRD Treatment Market Size by Country (2020-2025)
6.4 North America CKD and ESRD Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CKD and ESRD Treatment Market Size (2020-2031)
7.2 Europe CKD and ESRD Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CKD and ESRD Treatment Market Size by Country (2020-2025)
7.4 Europe CKD and ESRD Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CKD and ESRD Treatment Market Size (2020-2031)
8.2 Asia-Pacific CKD and ESRD Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CKD and ESRD Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific CKD and ESRD Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CKD and ESRD Treatment Market Size (2020-2031)
9.2 Latin America CKD and ESRD Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CKD and ESRD Treatment Market Size by Country (2020-2025)
9.4 Latin America CKD and ESRD Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CKD and ESRD Treatment Market Size (2020-2031)
10.2 Middle East & Africa CKD and ESRD Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CKD and ESRD Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa CKD and ESRD Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Details
11.1.2 Fresenius Business Overview
11.1.3 Fresenius CKD and ESRD Treatment Introduction
11.1.4 Fresenius Revenue in CKD and ESRD Treatment Business (2020-2025)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Details
11.2.2 DaVita Business Overview
11.2.3 DaVita CKD and ESRD Treatment Introduction
11.2.4 DaVita Revenue in CKD and ESRD Treatment Business (2020-2025)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter CKD and ESRD Treatment Introduction
11.3.4 Baxter Revenue in CKD and ESRD Treatment Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Details
11.4.2 Nipro Business Overview
11.4.3 Nipro CKD and ESRD Treatment Introduction
11.4.4 Nipro Revenue in CKD and ESRD Treatment Business (2020-2025)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun CKD and ESRD Treatment Introduction
11.5.4 B. Braun Revenue in CKD and ESRD Treatment Business (2020-2025)
11.5.5 B. Braun Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Details
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei CKD and ESRD Treatment Introduction
11.6.4 Asahi Kasei Revenue in CKD and ESRD Treatment Business (2020-2025)
11.6.5 Asahi Kasei Recent Development
11.7 Nikkiso
11.7.1 Nikkiso Company Details
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso CKD and ESRD Treatment Introduction
11.7.4 Nikkiso Revenue in CKD and ESRD Treatment Business (2020-2025)
11.7.5 Nikkiso Recent Development
11.8 WEGO
11.8.1 WEGO Company Details
11.8.2 WEGO Business Overview
11.8.3 WEGO CKD and ESRD Treatment Introduction
11.8.4 WEGO Revenue in CKD and ESRD Treatment Business (2020-2025)
11.8.5 WEGO Recent Development
11.9 Newsol
11.9.1 Newsol Company Details
11.9.2 Newsol Business Overview
11.9.3 Newsol CKD and ESRD Treatment Introduction
11.9.4 Newsol Revenue in CKD and ESRD Treatment Business (2020-2025)
11.9.5 Newsol Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic CKD and ESRD Treatment Introduction
11.10.4 Mayo Clinic Revenue in CKD and ESRD Treatment Business (2020-2025)
11.10.5 Mayo Clinic Recent Development
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Details
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight CKD and ESRD Treatment Introduction
11.11.4 Guangdong Biolight Revenue in CKD and ESRD Treatment Business (2020-2025)
11.11.5 Guangdong Biolight Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Details
11.12.2 Medtronic Business Overview
11.12.3 Medtronic CKD and ESRD Treatment Introduction
11.12.4 Medtronic Revenue in CKD and ESRD Treatment Business (2020-2025)
11.12.5 Medtronic Recent Development
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Details
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec CKD and ESRD Treatment Introduction
11.13.4 Sanxin Medtec Revenue in CKD and ESRD Treatment Business (2020-2025)
11.13.5 Sanxin Medtec Recent Development
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Details
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical CKD and ESRD Treatment Introduction
11.14.4 Jafron Biomedical Revenue in CKD and ESRD Treatment Business (2020-2025)
11.14.5 Jafron Biomedical Recent Development
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Details
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care CKD and ESRD Treatment Introduction
11.15.4 SWS Hemodialysis Care Revenue in CKD and ESRD Treatment Business (2020-2025)
11.15.5 SWS Hemodialysis Care Recent Development
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Details
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical CKD and ESRD Treatment Introduction
11.16.4 Tianyi Medical Revenue in CKD and ESRD Treatment Business (2020-2025)
11.16.5 Tianyi Medical Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Details
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca CKD and ESRD Treatment Introduction
11.17.4 AstraZeneca Revenue in CKD and ESRD Treatment Business (2020-2025)
11.17.5 AstraZeneca Recent Development
11.18 Vifor Pharma
11.18.1 Vifor Pharma Company Details
11.18.2 Vifor Pharma Business Overview
11.18.3 Vifor Pharma CKD and ESRD Treatment Introduction
11.18.4 Vifor Pharma Revenue in CKD and ESRD Treatment Business (2020-2025)
11.18.5 Vifor Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
NIKKISO
Wego
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic Inc
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Astrazeneca plc
Vifor Pharma
List of Tables
 Table 1. Global CKD and ESRD Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Medicine
 Table 3. Key Players of Hemodialysis
 Table 4. Key Players of Peritoneal Dialysis
 Table 5. Key Players of Kidney Transplantation
 Table 6. Global CKD and ESRD Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global CKD and ESRD Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global CKD and ESRD Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global CKD and ESRD Treatment Market Share by Region (2020-2025)
 Table 10. Global CKD and ESRD Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global CKD and ESRD Treatment Market Share by Region (2026-2031)
 Table 12. CKD and ESRD Treatment Market Trends
 Table 13. CKD and ESRD Treatment Market Drivers
 Table 14. CKD and ESRD Treatment Market Challenges
 Table 15. CKD and ESRD Treatment Market Restraints
 Table 16. Global CKD and ESRD Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global CKD and ESRD Treatment Market Share by Players (2020-2025)
 Table 18. Global Top CKD and ESRD Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CKD and ESRD Treatment as of 2024)
 Table 19. Ranking of Global Top CKD and ESRD Treatment Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by CKD and ESRD Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of CKD and ESRD Treatment, Headquarters and Area Served
 Table 22. Global Key Players of CKD and ESRD Treatment, Product and Application
 Table 23. Global Key Players of CKD and ESRD Treatment, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global CKD and ESRD Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global CKD and ESRD Treatment Revenue Market Share by Type (2020-2025)
 Table 27. Global CKD and ESRD Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global CKD and ESRD Treatment Revenue Market Share by Type (2026-2031)
 Table 29. Global CKD and ESRD Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global CKD and ESRD Treatment Revenue Market Share by Application (2020-2025)
 Table 31. Global CKD and ESRD Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global CKD and ESRD Treatment Revenue Market Share by Application (2026-2031)
 Table 33. North America CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America CKD and ESRD Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America CKD and ESRD Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe CKD and ESRD Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe CKD and ESRD Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific CKD and ESRD Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific CKD and ESRD Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific CKD and ESRD Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America CKD and ESRD Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America CKD and ESRD Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa CKD and ESRD Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa CKD and ESRD Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa CKD and ESRD Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Fresenius Company Details
 Table 49. Fresenius Business Overview
 Table 50. Fresenius CKD and ESRD Treatment Product
 Table 51. Fresenius Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 52. Fresenius Recent Development
 Table 53. DaVita Company Details
 Table 54. DaVita Business Overview
 Table 55. DaVita CKD and ESRD Treatment Product
 Table 56. DaVita Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 57. DaVita Recent Development
 Table 58. Baxter Company Details
 Table 59. Baxter Business Overview
 Table 60. Baxter CKD and ESRD Treatment Product
 Table 61. Baxter Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 62. Baxter Recent Development
 Table 63. Nipro Company Details
 Table 64. Nipro Business Overview
 Table 65. Nipro CKD and ESRD Treatment Product
 Table 66. Nipro Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 67. Nipro Recent Development
 Table 68. B. Braun Company Details
 Table 69. B. Braun Business Overview
 Table 70. B. Braun CKD and ESRD Treatment Product
 Table 71. B. Braun Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 72. B. Braun Recent Development
 Table 73. Asahi Kasei Company Details
 Table 74. Asahi Kasei Business Overview
 Table 75. Asahi Kasei CKD and ESRD Treatment Product
 Table 76. Asahi Kasei Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 77. Asahi Kasei Recent Development
 Table 78. Nikkiso Company Details
 Table 79. Nikkiso Business Overview
 Table 80. Nikkiso CKD and ESRD Treatment Product
 Table 81. Nikkiso Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 82. Nikkiso Recent Development
 Table 83. WEGO Company Details
 Table 84. WEGO Business Overview
 Table 85. WEGO CKD and ESRD Treatment Product
 Table 86. WEGO Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 87. WEGO Recent Development
 Table 88. Newsol Company Details
 Table 89. Newsol Business Overview
 Table 90. Newsol CKD and ESRD Treatment Product
 Table 91. Newsol Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 92. Newsol Recent Development
 Table 93. Mayo Clinic Company Details
 Table 94. Mayo Clinic Business Overview
 Table 95. Mayo Clinic CKD and ESRD Treatment Product
 Table 96. Mayo Clinic Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 97. Mayo Clinic Recent Development
 Table 98. Guangdong Biolight Company Details
 Table 99. Guangdong Biolight Business Overview
 Table 100. Guangdong Biolight CKD and ESRD Treatment Product
 Table 101. Guangdong Biolight Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 102. Guangdong Biolight Recent Development
 Table 103. Medtronic Company Details
 Table 104. Medtronic Business Overview
 Table 105. Medtronic CKD and ESRD Treatment Product
 Table 106. Medtronic Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 107. Medtronic Recent Development
 Table 108. Sanxin Medtec Company Details
 Table 109. Sanxin Medtec Business Overview
 Table 110. Sanxin Medtec CKD and ESRD Treatment Product
 Table 111. Sanxin Medtec Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 112. Sanxin Medtec Recent Development
 Table 113. Jafron Biomedical Company Details
 Table 114. Jafron Biomedical Business Overview
 Table 115. Jafron Biomedical CKD and ESRD Treatment Product
 Table 116. Jafron Biomedical Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 117. Jafron Biomedical Recent Development
 Table 118. SWS Hemodialysis Care Company Details
 Table 119. SWS Hemodialysis Care Business Overview
 Table 120. SWS Hemodialysis Care CKD and ESRD Treatment Product
 Table 121. SWS Hemodialysis Care Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 122. SWS Hemodialysis Care Recent Development
 Table 123. Tianyi Medical Company Details
 Table 124. Tianyi Medical Business Overview
 Table 125. Tianyi Medical CKD and ESRD Treatment Product
 Table 126. Tianyi Medical Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 127. Tianyi Medical Recent Development
 Table 128. AstraZeneca Company Details
 Table 129. AstraZeneca Business Overview
 Table 130. AstraZeneca CKD and ESRD Treatment Product
 Table 131. AstraZeneca Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 132. AstraZeneca Recent Development
 Table 133. Vifor Pharma Company Details
 Table 134. Vifor Pharma Business Overview
 Table 135. Vifor Pharma CKD and ESRD Treatment Product
 Table 136. Vifor Pharma Revenue in CKD and ESRD Treatment Business (2020-2025) & (US$ Million)
 Table 137. Vifor Pharma Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. CKD and ESRD Treatment Picture
 Figure 2. Global CKD and ESRD Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CKD and ESRD Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Medicine Features
 Figure 5. Hemodialysis Features
 Figure 6. Peritoneal Dialysis Features
 Figure 7. Kidney Transplantation Features
 Figure 8. Global CKD and ESRD Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global CKD and ESRD Treatment Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Kidney Dialysis Centers Case Studies
 Figure 12. At Homes Case Studies
 Figure 13. Others Case Studies
 Figure 14. CKD and ESRD Treatment Report Years Considered
 Figure 15. Global CKD and ESRD Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global CKD and ESRD Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global CKD and ESRD Treatment Market Share by Region: 2024 VS 2031
 Figure 18. Global CKD and ESRD Treatment Market Share by Players in 2024
 Figure 19. Global Top CKD and ESRD Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CKD and ESRD Treatment as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by CKD and ESRD Treatment Revenue in 2024
 Figure 21. North America CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America CKD and ESRD Treatment Market Share by Country (2020-2031)
 Figure 23. United States CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe CKD and ESRD Treatment Market Share by Country (2020-2031)
 Figure 27. Germany CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific CKD and ESRD Treatment Market Share by Region (2020-2031)
 Figure 35. China CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America CKD and ESRD Treatment Market Share by Country (2020-2031)
 Figure 43. Mexico CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa CKD and ESRD Treatment Market Share by Country (2020-2031)
 Figure 47. Turkey CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE CKD and ESRD Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Fresenius Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 51. DaVita Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 52. Baxter Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 53. Nipro Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 54. B. Braun Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 55. Asahi Kasei Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 56. Nikkiso Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 57. WEGO Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 58. Newsol Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 59. Mayo Clinic Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 60. Guangdong Biolight Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 61. Medtronic Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 62. Sanxin Medtec Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 63. Jafron Biomedical Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 64. SWS Hemodialysis Care Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 65. Tianyi Medical Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 66. AstraZeneca Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 67. Vifor Pharma Revenue Growth Rate in CKD and ESRD Treatment Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025
Global Chronic Kidney Disease Treatment Market Research Report 2025
Global End Stage Renal Disease ESRD Device Market Research Report 2024
Global Renal Therapeutic Market Research Report 2025
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global End Stage Kidney Disease Market Research Report 2024
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Global End Stage Renal Disease Treatment Market Research Report 2025
Kidney Renal Fibrosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global End Stage Renal Disease Market Research Report 2024
Global End stage Renal Disease Therapeutics Market Research Report 2024
Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Global Hemodialysis and Peritoneal Dialysis Machine Market Research Report 2024
Global Renal Disease Treatment Market Research Report 2024
Global Late Stage Chronic Kidney Disease Therapeutics Market Research Report 2024

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions